We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$194M
AUM Growth
-$4.43M
Cap. Flow
+$38.3M
Cap. Flow %
19.78%
Top 10 Hldgs %
32.5%
Holding
489
New
146
Increased
58
Reduced
57
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 12.38%
2 Industrials 11.28%
3 Consumer Discretionary 9.78%
4 Healthcare 9.65%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPXL
476
DELISTED
Impax Laboratories, Inc.
IPXL
-20
Closed
TIME
477
DELISTED
Time Inc.
TIME
$0 ﹤0.01%
+1
New +$15
SCLN
478
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
-76
Closed -$1K
CCP
479
DELISTED
Care Capital Properties, Inc.
CCP
-850
Closed -$24K
TEUM
480
DELISTED
Pareteum Corporation
TEUM
0
ARIA
481
DELISTED
Ariad Pharmaceuticals Inc
ARIA
-172
Closed -$2K
VA
482
DELISTED
Virgin America Inc.
VA
-250
Closed -$13K
ORIG
483
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
0
GSH
484
DELISTED
Guangshen Railway Co. Ltd
GSH
-100
Closed -$3K
MEMP
485
DELISTED
Memorial Production Partners LP Common Units
MEMP
$0 ﹤0.01%
+200
New +$155
PARN
486
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$0 ﹤0.01%
400

Similar funds

AlphaMark Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, AlphaMark Advisors held 489 positions worth $194M, down 2.2% from $198M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

AlphaMark Advisors deployed $38.3M of net new capital in Q4 2016, opening 146 new positions and adding to 58 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 200 shares worth $488K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $2.79M trimmed.

  • AlphaMark Advisors's largest Q4 2016 buy was Berkshire Hathaway Class A: 200 shares worth $488K.
  • AlphaMark Advisors added most to iShares iBonds Dec 2018 Term Corporate ETF in Q4 2016, an estimated $1.41M increase.
  • AlphaMark Advisors's biggest Q4 2016 reduction was Jazz Pharmaceuticals, cutting an estimated $2.79M.
  • AlphaMark Advisors fully exited Wabash National in Q4 2016, selling an estimated $939K.
  • AlphaMark Advisors's ten largest holdings make up 33% of its $194M portfolio in Q4 2016.
  • AlphaMark Advisors opened 146 new positions and closed 22 in Q4 2016.
  • AlphaMark Advisors's portfolio value fell 2.2% quarter-over-quarter to $194M.

Based on AlphaMark Advisors's 13F filing for Q4 2016, filed 26 Jan 2017.